Skip to main content
. 2016 Sep 8;7(43):69625–69637. doi: 10.18632/oncotarget.11904

Figure 5. GSK2830371 potentiates the apoptotic effects of Nutlin-3a, bortezomib, and doxorubicin.

Figure 5

Mantle cell lymphoma (MCL) cells were treated for 72 hours with GSK2830371 (GSK) and Nutlin-3a (N3a), bortezomib (BTZ), or doxorubicin (DOX) either as individual agents or in combination, after which the annexin V-positive fractions were determined. The combination index (CI) values for the apoptotic effect were calculated in Z-138 cells for each combination.